BMBL vs BTAI · rev $422.9M vs rev $388.0K
Bumble Inc (BMBL) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
Bumble Inc (BMBL) is a internet content & information company listed on US.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BMBL revenue for 2026-06-30 was $422.9M. Net income was -$64.8M. Revenue was up 99.1% from 2026-03-31 to 2026-06-30. BMBL currently screens at market cap $974.7M.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
BMBL currently screens at market cap $974.7M. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the BMBL and BTAI stock pages for the full models.
Not investment advice.